Absence of p53 mutations in malignant mesotheliomas

被引:75
作者
Mor, O
Yaron, P
Huszar, M
Yellin, A
Jakobivitz, O
BrokSimoni, F
Rechavi, G
Reichert, N
机构
[1] SACKLER SCH MED,RAMAT AVIV,ISRAEL
[2] CHAIM SHEBA MED CTR,DEPT CHEST SURG,RAMAT GAN,ISRAEL
[3] CHAIM SHEBA MED CTR,INST PULM,MOL BIOL LAB,RAMAT GAN,ISRAEL
[4] CHAIM SHEBA MED CTR,INST HEMATOL,MOL BIOL LAB,RAMAT GAN,ISRAEL
[5] CHAIM SHEBA MED CTR,INST PATHOL,MOL BIOL LAB,RAMAT GAN,ISRAEL
关键词
D O I
10.1165/ajrcmb.16.1.8998073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the p53 gene are the most common genetic alterations found in human malignancies. In this study, a search was done for mutations in the conserved regions of the p53 gene in malignant mesotheliomas. Thirteen malignant mesotheliomas collected over the preceding 12 yr and maintained in paraffin blocks were examined by polymerase chain reaction (PCR) followed by both single-strand conformation polymorphism (SSCP) and denaturing gradient-gel electrophoresis (DGGE). Direct sequence analysis was performed in cases suspected for mutations. No mutations in exons 5 to 8 of the p53 gene were detected. Our results suggest that malignant transformation of human mesothelioma cells does not require inactivation of p53 by point mutations in the conserved regions of the gene.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 44 条
[11]   ASBESTOS AND THE MESOTHELIAL CELL - A MOLECULAR TRAIL TO MITOGENIC STIMULI AND SUPPRESSOR GENE SUSPECTS [J].
GERWIN, BI .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (05) :507-508
[12]   CHROMOSOME CHANGES IN MALIGNANT MESOTHELIOMA [J].
GIBAS, Z ;
LI, FP ;
ANTMAN, KH ;
BERNAL, S ;
STAHEL, R ;
SANDBERG, AA .
CANCER GENETICS AND CYTOGENETICS, 1986, 20 (3-4) :191-201
[13]  
HANSTEEN IL, 1988, CANC GENET CYTOGENET, V70, P94
[14]   P53 - AT THE CROSSROADS OF MOLECULAR CARCINOGENESIS AND RISK ASSESSMENT [J].
HARRIS, CC .
SCIENCE, 1993, 262 (5142) :1980-1981
[15]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327
[16]   P53 EXPRESSION IS COMMON IN MALIGNANT MESOTHELIOMA [J].
KAFIRI, G ;
THOMAS, DM ;
SHEPHERD, NA ;
KRAUSZ, T ;
LANE, DP ;
HALL, PA .
HISTOPATHOLOGY, 1992, 21 (04) :331-334
[17]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[18]   IMMUNOHISTOCHEMICAL ANALYSIS OF THE P16(INK4) CYCLIN-DEPENDENT KINASE INHIBITOR IN MALIGNANT MESOTHELIOMA [J].
KRATZKE, RA ;
OTTERSON, GA ;
LINCOLN, CE ;
EWING, S ;
OIE, H ;
GERADTS, J ;
KAYE, FJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (24) :1870-1875
[19]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[20]  
LEEJACKSON D, 1993, BIOTECHNIQUES, V15, P363